| Alflutinib |
Alflutinib |
1869057-83-9 |
| MGV354 |
MGV354 |
1852495-86-3 |
| Dersimelagon |
Dersimelagon |
1835256-48-8 |
| Fmoc-Ala-Ala-Asn(Trt)-PAB |
ALA-ALA-ASN(TRT)-PAB |
1834515-99-9 |
| pythiDC |
化合物PYTHIDC |
1821370-71-1 |
| LEM-14 |
化合物 T9006 |
1814881-70-3 |
| KL-1333 |
KL1333 |
1800405-30-4 |
| BIIB068 |
BIIB068 |
1798787-27-5 |
| 1-(tert-butoxycarbonyl)-2,2-dimethylpiperidine-4-carboxylic acid |
1-(tert-butoxycarbonyl)-2,2-dimethylpiperidine-4-carboxylic acid |
1785482-91-8 |
| ERK-IN-1 |
ERK-IN-1 (COMPOUND B) |
1715025-32-3 |
| BMS 986188 |
BMS 986188 |
1776115-10-6 |
| N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide |
PF-06747775 |
1776112-90-3 |
| 2,3-Dimethyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride |
1774899-05-6 |
1774899-05-6 |
| Rac-PT2399 |
(RAC)-PT2399 |
1672662-07-5 |
| Fmoc-Phe-Cit-PAB |
Fmoc-Phe-Cit-PAB |
1656305-20-2 |
| SCO-267 |
SCO-267 |
1656261-09-4 |
| Fremanezumab |
瑞玛奈珠单抗 |
1655501-53-3 |
| GSK106 (hydrochloride) |
GSK106 (hydrochloride) |
1652591-82-6 |
| GSK121 (trifluoroacetate salt) |
GSK121 (trifluoroacetate salt) |
1652591-80-4 |
| Eptinezumab |
依普奈珠单抗 |
1644539-04-7 |
QQ
微信
